Help Your Depression Patients with Brainsway Transcranial Magnetic Stimulation

    Brainsway Deep TMS

   (Deep Transcranial

   Magnetic Stimulation):

  • Dramatic improvement within just 4-6 weeks for many patients
  • Helps even severe, persistent, drug resistant depression*
  • No systemic side effects*
  • FDA cleared*

Are many of your depression patients disappointed with the results, or the uncomfortable side effects, of antidepressants? Are they considering ECT, but fearing its risks, or worse yet, are they on the verge of despair?

Brainsway Deep Transcranial Magnetic Stimulation can be an ideal solution for depression patients. Brainsway Transcranial Magnetic Stimulation depression treatment is a safe, non-invasive depression therapy which stimulates the brain regions responsible for depression and brings dramatic improvement without causing systemic side effects*. An effective treatment, Brainsway Deep TMS can bring tangible results within 4-6 weeks, and has been clinically proven for patients with severe, persistent, drug-resistant depression*.

FDA-Cleared for Treating Persistent Depression

Brainsway Deep TMS has been cleared by the FDA for patients who tried any number of antidepressants unsuccessfully. The FDA indication is based on a double blind, placebo-controlled, multi-center study*, which enrolled over 200 subjects, and reported a marked decline in HDRS-21 scores, as well as significant remission (32.6%) and response (38.4%) rates. In the study, Brainsway's treatment was generally well tolerated, and the treatment was well tolerated by the majority of the study subjects. 

An optimal for Major Depressive Disorder

Brainsway Transcranial Magnetic Stimulation has many advantages over other treatment options. It has no systemic side effects like those typical of many antidepressants*, does not entail hospitalization, has no reported memory loss like that associated with ECT*, and offers much shorter (almost 50%) sessions than traditional TMS. 

Advanced, widely tested technology

Brainsway's Deep TMS therapy is based on patents filed by the U.S. National Institutes of Health (NIH) and the company. The treatment was implemented in over 60 clinical trials in leading institutions worldwide.

* For references click here    

© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use